Psoriasis Literature Highlights - December2024

Renkhold et al. report that secukinumab significantly reduced psoriasis-associated pruritus intensity, improved skin lesions, and normalised histopathological changes, with stable neuroanatomy despite treatment discontinuation.

Keywords:

  • Efficacy, IL-17, Outcomes, Saftey, Secukimumab
  • Literature review thumbnail: Psoriasis Literature Highlights - December2024